Ameritas Investment Partners’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Ameritas Investment Partners’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,609	Closed	-$8K	–	3314
2022 Q1	$8K	Hold	2,609	–	–	﹤0.01%	2874
2021 Q4	$12K	Hold	2,609	–	–	﹤0.01%	2854
2021 Q3	$20K	Hold	2,609	–	–	﹤0.01%	2716
2021 Q2	$19K	Buy	+2,609	New	+$20.1K	﹤0.01%	2770
2019 Q2	–	Sell	-567	Closed	-$3K	–	3130
2019 Q1	$3K	Hold	567	–	–	﹤0.01%	2927
2018 Q4	$2K	Hold	567	–	–	﹤0.01%	2965
2018 Q3	$6K	Hold	567	–	–	﹤0.01%	2938
2018 Q2	$9K	Buy	+567	New	+$8.21K	﹤0.01%	2870

Other funds holding SURF

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameritas Investment Partners's SURF Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2022, closing a stake of 2,609 shares — an estimated $8K sold.

Ameritas Investment Partners first reported a position in SURF in Q2 2018 and held it in 8 quarters. The position peaked at $20K in Q3 2021. 84 funds tracked by Wall St. Rank hold SURF as of Q2 2022.

Ameritas Investment Partners reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 2,609 Surface Oncology, Inc. Common Stock shares in Q2 2022, an estimated $8K.
Ameritas Investment Partners first reported a position in Surface Oncology, Inc. Common Stock in Q2 2018 and held it in 8 quarters.
Ameritas Investment Partners's Surface Oncology, Inc. Common Stock position peaked at $20K in Q3 2021.
84 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.